FDCTech Restates Q1 2026 Financials, Discloses Material Weaknesses, and Issues Non-Reliance Notice on Prior Reports
Summary
FDCTech restated its Q1 2026 financials, revealing material weaknesses in internal controls and a non-reliance notice on multiple past financial reports, signaling significant financial reporting issues.
Key Events · Legal and Risk Events · FDCT
-
Q1 2026 Financial Restatement
FDCTech restated its unaudited condensed consolidated financial statements for the three months ended March 31, 2026, correcting errors related to general and administrative expenses, interest income reporting, and noncontrolling interest attribution. Net income attributable to FDCTech, Inc. stockholders decreased by $2,654 to $6,867,266.
-
Material Weaknesses in Internal Controls
The company identified material weaknesses in internal control over financial reporting concerning consolidation and intercompany eliminations, noncontrolling interest attribution, account classification and footing review, and lease accounting updates. Management concluded that disclosure controls and procedures were not effective.
-
Non-Reliance on Prior Financial Statements
The Board of Directors concluded on June 3, 2026, that previously issued financial statements for Q1 2026, Q1, Q2, Q3 2025, FY 2024, and FY 2025 should no longer be relied upon. This 10-Q/A is part of a series of concurrent filings to restate these periods.
-
Balance Sheet Adjustments
As a result of the restatement, total assets increased by $611,895 to $72,807,161, total liabilities increased by $338,130 to $38,920,903, and total FDCTech, Inc. stockholders' equity increased by $276,973 to $33,845,667 as of March 31, 2026.
Analysis · FDCT · Technology
This filing is a critical event as FDCTech has restated its Q1 2026 financial statements due to errors and disclosed multiple material weaknesses in internal controls over financial reporting. The company also issued a non-reliance notice on its previously issued Q1 2026 financials, as well as other prior period reports (Q1, Q2, Q3 2025, FY 2024, and FY 2025). This indicates systemic issues with financial reporting and internal controls, severely impacting the credibility of the company's financial disclosures. While the numerical adjustments for Q1 2026 are relatively small, the underlying control deficiencies and the non-reliance notice are highly significant for investor confidence and regulatory compliance.
At the time of this filing, FDCT was trading at $0.06 on OTC in the Technology sector, with a market capitalization of approximately $25.8M. The 52-week trading range was $0.00 to $0.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.